Physician-developed, coverage-analyst-validated, AI used selectively, your team in control.
Or pilot Ginseng on up to 10 of your own protocols, so your team can see how it handles different study designs.
Ginseng Coverage Analysis is clinical trial coverage analysis software that takes a protocol — including its qualifying clinical trial (QCT) determination — to an audit-ready billing grid, grounded in NCD 310.1 Medicare coverage analysis rules, NCCN guidelines, FDA labels, MAC jurisdiction logic, eviCore and Children's Oncology Group (COG) guidelines.
15–50 days → under 30 minutes* (per site-reported benchmarks)
Typically 25–33% below the cost of outsourced coverage analysis, with the work kept in-house.
Includes: QCT, billing grid with justifications, amendment comparison, CPT and chargemaster codes, and pediatric protocols. Free for your institutional IITs.
A quick walkthrough of how Ginseng takes a protocol from upload to audit-ready billing grid.
Track coverage analyses across review states with completion times, sponsors, and PIs at a glance.
Role-based access for PIs, QAMs and coverage analysts. Your protocols are never used to train models, and are deleted on your schedule.
Guided steps capture protocol details, schedule of events, and objectives in minutes.
Sponsor (S), Routine costs (N) and Non-billable (NB) assignments per visit and assessment.
Configured with your chargemaster and CPT codes, and your institution's guidelines and risk tolerance, so every coverage analysis looks and reads like your own.
“It [CA billing grid output] looks just like our template. That's amazing.”
Every trial activation depends on a coverage analysis. When that analysis relies on manual cross-referencing, sites pay the price in lost time and audit risk.
15 to 50 Days
At benchmarked cancer centers, manually building a protocol's billing grid and coverage determination takes 15 to 50 days — time the trial spends waiting before it can activate.
Per site-reported benchmarks.
Outsourcing Isn't Cheap
Many sites outsource coverage analysis to third parties at a premium, study after study — without actually shortening the timeline or keeping the work in-house.
Fragmented & Hard to Audit
Cross-referencing NCD 310.1, NCCN guidelines, FDA labels, MAC jurisdiction logic, eviCore and COG guidelines by hand leaves a trail that's difficult to defend during an audit — putting research billing compliance at risk.
Coverage analysis automation that still puts every determination in front of your team before it's final.
Add Study
Guided steps capture protocol details, the schedule of events, and study objectives in minutes — no blank templates, no re-keying data your team already has.
Physician-Developed Rules Engine
Ginseng cross-references each visit and assessment against NCD 310.1, NCCN guidelines, FDA drug labels, MAC jurisdiction logic, eviCore imaging and Children's Oncology Group (COG) guidelines — calibrated to your institution's risk tolerance.
Illustrative preview — calibrated to institutional risk tolerance.
Billing Grid
Sponsor (S), routine cost (N), and non-billable (NB) assignments per visit and assessment, with justifications attached, ready for budgeting and sponsor negotiation.
Dashboard & Secure Access
Track coverage analyses across review states with completion times, sponsors and PIs at a glance. Role-based access for PIs, QAMs and coverage analysts — your protocols are never used to train models, and are deleted on your schedule.
Bring coverage analysis in-house, without the hiring challenge. Ginseng Coverage Analysis is a force multiplier for your team, not a replacement.
| Operational Dimension | Traditional Manual Method | With Ginseng |
|---|---|---|
| Coverage Analysis Turnaround | 15 to 50 days per protocol | Under 30 minutes |
| Cost | Outsourced vendors, ad hoc pricing per study | Typically 25–33% below outsourced CA cost |
| Guideline Grounding | Judgment calls, analyst by analyst | NCD 310.1, NCCN, FDA labels, eviCore, COG guidelines |
| Audit Trail | Scattered spreadsheets and email chains | Audit-ready billing grid with justifications |
| Time-to-Activation | Coverage analysis bottlenecks study start-up | Frees up weeks for faster trial activation |
* Per site-reported benchmarks. Savings depend on volume, contract length and program specifics.
I would happily do this [Ginseng CA Process] 20 times rather than spend hours on the same CA in our current system [process].
NCI-Designated Clinical Cancer Center
This [Ginseng] looks much more implementable [compared to other systems]. Once we have the institutional specifics [guidelines and risk tolerance] configured [in Ginseng], we'll have a really impactful product for CA.
Clinical Trials Office, NCI-Designated Comprehensive Cancer Center
It [CA billing grid output] looks just like our template. That's amazing.
NCI-Designated Cancer Center
Answer a few questions about your study volume and current process to see the time and cost impact, side by side with your current workflow.
Bring a protocol and watch Ginseng turn it into an audit-ready billing grid, live.
Free for institutional investigator-initiated trials (IITs), because we want to promote clinical research.
